Actionable insights straight to your inbox

Equities logo

Merck & Co. Inc. Files SEC Form SC TO-T, Tender Offer Statement By Third Party [Amend] (Jun. 27, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Merck & Co. Inc. (Form SC TO-T) was posted on June 27, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There was one document filed with this form. The SEC file number is 0001193125-14-253298.
The contact information for this company is ONE MERCK DRIVE, P.O. BOX 100, WHITEHOUSE STATION NJ 08889-0100, 908-423-1000.
Our editors provided additional information about Form SC TO-T: Tender offer statement by Third Party. Replaces SC 14D-1 as of January 2000.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1093649/0001193125-14-253298-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Merck & Co. Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Why have three of the most successful men in Silicon Valley decided to branch out from computing and into nuclear energy?